首页> 外文期刊>Molecules >Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates
【24h】

Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates

机译:结核分枝杆菌重组抗原蛋白的糖基化:蛋白表位的计算机模拟预测和新半合成糖缀合物的体外生物学评价

获取原文
           

摘要

Tuberculosis is still one of the most deadly infectious diseases worldwide, and the use of conjugated antigens, obtained by combining antigenic oligosaccharides, such as the lipoarabinomannane (LAM), with antigenic proteins from Mycobacterium tuberculosis (MTB), has been proposed as a new strategy for developing efficient vaccines. In this work, we investigated the effect of the chemical glycosylation on two recombinant MTB proteins produced in E. coli with an additional seven-amino acid tag (recombinant Ag85B and TB10.4). Different semi-synthetic glycoconjugated derivatives were prepared, starting from mannose and two disaccharide analogs. The glycans were activated at the anomeric position with a thiocyanomethyl group, as required for protein glycosylation by selective reaction with lysines. The glycosylation sites and the ex vivo evaluation of the immunogenic activity of the different neo-glycoproteins were investigated. Glycosylation does not modify the immunological activity of the TB10.4 protein. Similarly, Ag85B maintains its B-cell activity after glycosylation while showing a significant reduction in the T-cell response. The results were correlated with the putative B- and T-cell epitopes, predicted using a combination of in silico systems. In the recombinant TB10.4, the unique lysine is not included in any T-cell epitope. Lys30 of Ag85B, identified as the main glycosylation site, proved to be the most important site involved in the formation of T-cell epitopes, reasonably explaining why its glycosylation strongly influenced the T-cell activity. Furthermore, additional lysines included in different epitopes (Lys103, -123 and -282) are also glycosylated. In contrast, B-cell epitopic lysines of Ag85B were found to be poorly glycosylated and, thus, the antibody interaction of Ag85B was only marginally affected after coupling with mono- or disaccharides. View Full-Text
机译:结核病仍然是世界上最致命的传染病之一,结合抗原的使用是通过将抗原性寡糖(如脂阿拉伯糖甘露聚糖(LAM))与结核分枝杆菌(MTB)的抗原蛋白相结合而获得的。用于开发有效的疫苗。在这项工作中,我们调查了化学糖基化对大肠杆菌中产生的带有两个七氨基酸标签(重组Ag85B和TB10.4)的两种重组MTB蛋白的影响。从甘露糖和两个二糖类似物开始,制备了不同的半合成糖共轭衍生物。根据蛋白质糖基化的要求,通过与赖氨酸的选择性反应,在异头位置用硫氰基甲基激活聚糖。研究了不同新糖蛋白的糖基化位点和免疫原性的离体评估。糖基化不会改变TB10.4蛋白的免疫活性。同样,Ag85B在糖基化后仍保持其B细胞活性,而T细胞反应却显着降低。结果与推定的B细胞和T细胞表位相关联,这些表位是结合计算机系统预测的。在重组TB10.4中,独特的赖氨酸不包含在任何T细胞表位中。被证实是主要糖基化位点的Ag85B的Lys30被证明是参与T细胞表位形成的最重要位点,从而合理地解释了其糖基化强烈影响T细胞活性的原因。此外,包括在不同表位(Lys103,-123和-282)中的其他赖氨酸也被糖基化。相反,发现Ag85B的B细胞表位赖氨酸的糖基化较差,因此,与单糖或双糖偶联后,Ag85B的抗体相互作用仅受到很小的影响。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号